References
- Burstein S.A., Downs T., Friese P., Lynam S., Anderson S., Henthorn J., Epstein R.B. Thrombocytopoiesis in normal and sublethally irradiated dogs. Blood 1992; 80: 420–428
- Herodin F., Mestries J.C., Janodet D., Martin S., Mathieu J., Gascon M.P., Pernin M.O., Ythier A. Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboons. Blood 1992; 80: 688–695
- MacVittie T.J., Farese A.M., Patchen M.L., Myers L.A. Therapeutic efficacy of recombinant Interleukine-6 (IL-6) alone and combined with recombinant human IL-6 in a nonhuman primate model of high-dose, sublethal radiation-induced marrow aplasia. Blood 1994; 84: 2515–2522
- Selig C., Kreja L., Muller H., Seifried E., Nothdurft W. Hematological effects of recombinant human interleukin-6 in dogs exposed to a total-body radiation dose of 2·4 Gy. Experimental Hematology 1994; 22: 551–558
- Thierry D., Gourmelon P., Parmentier C., Nénot S.C. Haematopoietic growth factors in the treatment of therapeutic and accidental irradiation-induced bone marrow aplasia. International Journal of Radiation Biology 1995; 67: 103–117
- Zeidler C., Kanz L., Hurkuck, Rittmann R.L., Wildfang I., Kadoya T., Mikayama T., Souza L., Welte K. In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates. Blood 1992; 80: 2740–2745